Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Long-Term Results Underscore Value of Early MS Treatment
Myelin Basic Protein-Specific TCR/HLA-DRB5*01:01 Transgenic Mice Support the Etiologic Role of DRB5*01:01 in Multiple Sclerosis.
Influence of pregnancy on neuromyelitis optica spectrum disorder.
Progressive multiple sclerosis: The treatment gap.
Therapeutic laquinimod treatment decreases inflammation, initiates axon remyelination, and improves motor deficit in a mouse model of multiple sclerosis.
Neuroproteomics and microRNAs studies in multiple sclerosis: transforming research and clinical knowledge in biomarker research.
Incidence of multiple sclerosis in Northern Lisbon, Portugal: 1998¿2007.
Severe disease reactivation in four patients with relapsing-remitting multiple sclerosis after fingolimod cessation.
Simvastatin shows promise in treating progressive multiple sclerosis, study finds.
Sleep Disorders and Multiple Sclerosis: A Clinical and Polysomnography Study.
How Natalizumab Binds and Antagonizes α4 Integrins.
Reduced expression of PGC-1α partly underlies mitochondrial changes and correlates with neuronal loss in multiple sclerosis cortex.
Effects of Panax ginseng in Neurodegenerative Diseases.
Infectious causes of multiple sclerosis.
Multiple sclerosis treatment: current best practice.
Modeling of cognitive impairment by disease duration in multiple sclerosis: a cross-sectional study.
New Disease-Modifying Therapies and New Challenges for MS.
Aquaporin 4-specific T cells in neuromyelitis optica exhibit a Th17 bias and recognize Clostridium ABC transporter.
miRNA in multiple sclerosis: search for novel biomarkers.
Efficacy of idebenone for respiratory failure in a patient with Leigh syndrome: a long-term follow-up study.
Immunosuppressive and anti-angiogenic sphingosine 1-phosphate receptor-1 agonists induce ubiquitinylation and proteasomal degradation of the receptor.
Bayer Receives FDA Approval for BETACONNECT - First and Only Electronic Autoinjector in Relapsing-Remitting Multiple Sclerosis (RRMS) Treatment
Dalfampridine Effects Beyond Walking Speed in Multiple Sclerosis.
MARGA: Multispectral Adaptive Region Growing Algorithm for brain extraction on axial MRI.
High-dose cyclophosphamide in multiple sclerosis patients undergoing autologous stem cell transplantation.
Pages
« first
‹ previous
…
162
163
164
165
166
167
168
169
170
…
next ›
last »